| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 30 May 2025 | 27 May 2025 |
| Remedium Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 inter alia to consider and approve the Audited Financial Results for the quarter and Financial Year ended 31st March 2025 Appointment of Company Secretary and Compliance Officer (As Per BSE Announcement Dated on: 30.05.2025) | ||
| Board Meeting | 22 May 2025 | 22 May 2025 |
| Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. | ||
| Board Meeting | 24 Apr 2025 | 17 Apr 2025 |
| Remedium Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/04/2025 inter alia to consider and approve 1. To Approve the Letter of Offer (LOF) for the proposed Rights Issue of 491904000 Equity Shares of Re. 1/- each aggregating to 4919.04 lakhs for shareholders of the Company. 2. Any other item with the permission of the Chair and Majority of Directors. The Board of Directors of the Company at its meeting held today, i.e. April 24, 2025 have considered and approved inter alia the following: 1. The Letter of Offer, Abridged Letter of Offer, Rights Entitlement Letter, Application Form and other issue related terms and documents. The Letter of Offer to be filed with BSE Limited. 2. Rights Issue Period: ISSUE OPENING DATE APRIL 30, 2025 ISSUE CLOSING DATE May 14, 2025. (As Per BSE Announcement Dated on: 24/04/2025) | ||
| Board Meeting | 7 Apr 2025 | 1 Apr 2025 |
| Remedium Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/04/2025 inter alia to consider and approve 1. To consider and approve the number of shares to be issued on a rights basis issue price rights entitlement ratio for the proposed Right Issue. 2. To fix Record Date to ascertain the eligible shareholders for the proposed Right Issue and other matters and terms and conditions incidental or connected therewith. 3. Any other item with the permission of the Chair and Majority of Directors. Board approved :- 1. Considered, approved and fixed Tuesday, 15 April, 2025 as the Record Date for the purpose of determining the equity shareholders entitled to receive rights entitlements in the Rights Issue; 2. Considered and approved the following terms of the right issue. a. Ratio: 61 (Sixty-One) Rights Equity Shares for every 50 (Fifty) Fully Paid Equity Shares held by the Existing Shareholders on the Record Date. Outcome of Board Meeting held on April 07, 2025 for 1)Considering approving and fixing Tuesday, 15 April, 2025 as the Record Date for the purpose of determining the equity shareholders entitled to receive rights entitlements in the Rights Issue; 2) Considering and approving the terms of the right issue (As Per BSE Announcement Dated on 07.04.2025) | ||
| Board Meeting | 14 Feb 2025 | 8 Feb 2025 |
| Remedium Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 inter alia to consider and approve 1) Consideration And Approval Of The Unaudited Financial Results For The Quarter Ended 31st December 2024. 2) Any Other Business With The Permission Of The Chair. Outcome of Board Meeting held on Friday, February 14, 2025. (As Per Bse Announcement Dated on 14.02.2025) | ||
| Board Meeting | 25 Jan 2025 | 25 Jan 2025 |
| Outcome of Board Meeting for approval of Draft Letter of Offer in regards to the Rights Issue of Equity Shares. | ||
| Board Meeting | 22 Jan 2025 | 17 Jan 2025 |
| Remedium Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/01/2025 inter alia to consider and approve raising funds by way of issue of fresh equity shares through Right Issue basis along-with other matter if any as may be permitted under applicable laws subject to such regulatory/statutory approvals as may be required. 2) Any other business with the permission of the Chair. Outcome of Board Meeting held on Wednesday, January 22, 2025 for 1) Right issue of shares 2) Increase in authorised share capital 3) Appointment of Additional Independent Director (As Per BSE Announcement dated on 22.01.2025) | ||
| Board Meeting | 14 Nov 2024 | 9 Nov 2024 |
| Remedium Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 inter alia to consider and approve Remedium Lifecare Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 inter alia to consider and approve 1) Consideration And Approval Of The Unaudited Financial Results For The Quarter and Half Year Ended 30th September 2024.2) Any other business with the permission of the Chair Outcome of Board Meeting held on Thursday, November 14, 2024. (As per BSE Announcement Dated on 14/11/2024) | ||
| Board Meeting | 31 Oct 2024 | 31 Oct 2024 |
| In terms of Regulation 30 of SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015 read with Part A of Schedule III, We are pleased to inform you that the Board of Directors in their meeting held today on 31st October 2024 at the Registered Office of the Company at 1.00 P.M | ||
| Board Meeting | 4 Sep 2024 | 27 Aug 2024 |
| Remedium Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/09/2024 inter alia to consider and approve 1. Acquisition of a company Airowater Global Trading LLC UAE which is into Water Injectables for Pharma Production. 2. Consideration of issuing of Foreign Currency Convertible Bonds (FCCBs) 3. Any other business with the permission of the Chair The Board Meeting to be held on 03/09/2024 has been revised to 04/09/2024 The Board Meeting to be held on 03/09/2024 has been revised to 04/09/2024 inter alia 1. To Consider Acquisition of AirOWater Global Trading LLC, UAE:The Board will review the proposal to acquire a substantial stake in AirOWater Global Trading LLC, a pioneering entity in the production of the purest form of drinking water via Atmospheric Water Generators (AWGs). This technology, recognised as one of the most sustainable solutions to the pressing issue of global water scarcity, has successfully catered to diverse sectors including Government Institutions, Corporates, Hospitality chains, Supermarkets, Hospital chains, Educational institutions, and Community Centres. 2. To Consider issuing of Foreign Currency Convertible Bonds (FCCBs). 3. Any other business with the permission of the Chair. (As per BSE Announcement Dated on 28/08/2024) Outcome of the Board Meeting held on 04th September, 2024 (As per BSE Announcement Dated on 04/09/2024) | ||
| Board Meeting | 14 Aug 2024 | 15 Jul 2024 |
| Remedium Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2024 inter alia to consider and approve 1) Consideration And Approval Of The Unaudited Financial Results For The Quarter Ended 30th June 2024. 2) Consideration of acquisition of an unlisted company in the specialty chemicals sector with a global footprint. 3) Authorise the board to approve the transaction structure valuation and timelines given the preliminary nature of the discussions. 4) Ratify the transaction in a subsequent Extraordinary General Meeting (EGM) or through Postal Ballot. The Board Meeting to be held on 08/08/2024 has been revised to 14/08/2024 The Board Meeting to be held on 08/08/2024 has been revised to 14/08/2024 (As per BSE Announcement Dated on 07/08/2024) With reference to the captioned subject and our announcement dated August 14, 2024, please find below corrigendum to the outcome of Board Meeting. 1. In the said announcement, in body of covering letter while uploading on BSE in corporate announcement it is incorrectly mentioned as meeting held on August 12, 2023 instead of meeting held on August 14, 2024. The Date of said Board Meeting is August 14, 2024, kindly read it as August 14, 2024. 2. In Body of covering letter while uploading on BSE in corporate announcement it is incorrectly mentioned as Financial Result for quarter ended June 30, 2023 instead of Financial Result for quarter ended June 30, 2024. The said result is pertaining to Financial Result for quarter ended June 30, 2024, kindly read it as Financial Result for quarter ended June 30, 2024. Read less.. (As Per BSE Announcement Dated on 16.08.2024) | ||
| Board Meeting | 14 Aug 2024 | 14 Aug 2024 |
| Outcome of Board Meeting held on Wednesday, August 14, 2024. | ||
| Board Meeting | 20 Jul 2024 | 17 Jul 2024 |
| Remedium Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/07/2024 inter alia to consider and approve 1) Increase in Authorized Capital of the Company and consequent alteration in Capital Clause of the Memorandum of Association of the Company. 2) To consider & approve the Draft Postal Ballot Notice of the Company and fixing of date of Book closure and e-voting period 3) To appoint Scrutinizer for conducting E- voting process. 4) Any other business with the permission of the Chair 1) increase in Authorized Share Capital of the Company from Rs. 42,00,00,000/- (Rupees Forty Two Crores Only) divided into 42,00,00,000 (Forty Two Crores) Equity Shares of Re. 1/- (Rupee One Only) each to Rs. 60,00,00,000/- (Rupees Sixty Crores Only) divided into 60,00,00,000 (Sixty Crores Only) Equity Shares of Re. 1/- (Rupee One Only) each and consequent Alteration in Capital Clause of the Memorandum of Association of the Company. 2) Approved Draft Postal Ballot Notice pursuant to Section 110 of the Companies Act, 2013 and other applicable provisions 3) appointment of Scrutinizer for conducting Postal Ballot 4) Cut Off date for determining shareholders eligible to vote. (As per BSE Announcement Dated on 20/07/2024) | ||
| Board Meeting | 8 Jul 2024 | 2 Jul 2024 |
| Remedium Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/07/2024 inter alia to consider and approve Intimation of the Board Meeting under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 Outcome of Board Meeting dated July 08, 2024: 1. Fund Raising through Qualified Institutional Placement (QIP) 2. Allotment of Bonus Shares Kindly take the above on record. (As per BSE Announcement Dated on 08/07/2024) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.